Doctor profile · Federal record
Dr. Charles Brown, PA-C
Medical Physician Assistant (CMS: Physician Assistant) · Baltimore, MD
- NPI 1487803003
- Accepts Medicare
- MIPS 75.6 / 100 · 2023
- 18 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
900 Caton Ave # 230
Baltimore, MD 212295201
(410) 368-8902
fax (410) 368-3534
Credentials & registration
- NPI registered
- September 2008 — 18 yrs on file
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State license (1)
- Maryland #PENDING
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1487803003. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,185
Distinct HCPCS
10
Medicare allowed
$251,626
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,260 | 217 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 694 | 525 | $76 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 382 | 252 | $108 | |
17000 |
Destruction of precancer skin growth, 1 growth | 353 | 275 | $42 | |
17110 |
Destruction of skin growth, 1-14 growths | 324 | 250 | $96 | |
11102 |
Biopsy of related skin growth, first growth | 286 | 246 | $75 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 114 | 102 | $48 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 114 | 42 | $1 | |
11103 |
Biopsy of related skin growth, each additional growth | 113 | 74 | $43 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 107 | 107 | $95 |
In context: peer comparison
Among 41 peers in Baltimore Medical Physician Assistant, average services per provider: 107. This provider delivers 39× the peer median.Open Payments
Industry payments received
All-time total
$1,620
Transactions
81
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 6 | $252.07 | |
| Abbvie INC. | 13 | $208.91 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $168.79 | |
| Janssen Biotech, INC. | 11 | $163.39 | |
| Leo Pharma INC. | 10 | $133.60 | |
| Amgen INC. | 4 | $114.30 | |
| Pfizer INC. | 6 | $98.32 | |
| Novartis Pharmaceuticals Corporation | 3 | $76.91 | |
| Ucb, INC. | 3 | $69.70 | |
| Lilly USA, LLC | 3 | $66.22 | |
| Genentech USA, INC. | 3 | $64.29 | |
| Regeneron Healthcare Solutions, INC. | 3 | $60.35 | |
| Arcutis Biotherapeutics, INC. | 3 | $45.01 | |
| Sun Pharmaceutical Industries INC. | 2 | $42.39 | |
| Incyte Corporation | 1 | $23.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
712
Patients
366
Total drug cost
$125,089
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 174 | 93 | $11,187 |
| Ketoconazole | Generic | 110 | 66 | $2,530 |
| Doxycycline Hyclate | Generic | 89 | 29 | $2,779 |
| Minoxidil | Generic | 74 | 18 | $585 |
| Triamcinolone Acetonide | Generic | 53 | 38 | $390 |
| Hydrocortisone | Generic | 42 | 33 | $726 |
| Betamethasone Dipropionate | Generic | 30 | 22 | $1,608 |
| Dupixent Pen (Dupilumab) | Brand | 26 | 0 | $100,749 |
| Prednisone | Generic | 21 | 17 | $110 |
| Metronidazole | Generic | 18 | 14 | $1,218 |
Frequently asked questions
What is Dr. Charles Brown's medical specialty?
Dr. Charles Brown practices Medical Physician Assistant in Baltimore, MD.
Where does Dr. Charles Brown practice?
Dr. Charles Brown practices at 900 Caton Ave # 230, Baltimore, MD 212295201. Office phone: 4103688902.
What is Dr. Charles Brown's NPI?
Dr. Charles Brown's National Provider Identifier (NPI) is 1487803003, issued by NPPES.
Does Dr. Charles Brown accept Medicare assignment?
Yes. Dr. Charles Brown accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Brown commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.